Does PEMBROLIZUMAB Cause Hepatic cytolysis? 601 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 601 reports of Hepatic cytolysis have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.7% of all adverse event reports for PEMBROLIZUMAB.
601
Reports of Hepatic cytolysis with PEMBROLIZUMAB
0.7%
of all PEMBROLIZUMAB reports
30
Deaths
311
Hospitalizations
How Dangerous Is Hepatic cytolysis From PEMBROLIZUMAB?
Of the 601 reports, 30 (5.0%) resulted in death, 311 (51.7%) required hospitalization, and 21 (3.5%) were considered life-threatening.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEMBROLIZUMAB. However, 601 reports have been filed with the FAERS database.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
PEMETREXED (252)
Which PEMBROLIZUMAB Alternatives Have Lower Hepatic cytolysis Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G